{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:02:50Z","timestamp":1774969370566,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200181"],"award-info":[{"award-number":["82200181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"School and Hospital Joint Fund of the Second Affiliated Hospital of Chinese University of Hong Kong, Shenzhen","award":["YXLH2203"],"award-info":[{"award-number":["YXLH2203"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010128"],"award-info":[{"award-number":["2022A1515010128"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016691","name":"Guangdong Provincial Pearl River Talents Program","doi-asserted-by":"publisher","award":["2021QN02Y438"],"award-info":[{"award-number":["2021QN02Y438"]}],"id":[{"id":"10.13039\/100016691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016804","name":"Natural Science Foundation of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20230807141759001"],"award-info":[{"award-number":["JCYJ20230807141759001"]}],"id":[{"id":"10.13039\/100016804","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Fund Project for Economic and Technological Development of Longgang District, Shenzhen","award":["LGKCYLWS2021000008"],"award-info":[{"award-number":["LGKCYLWS2021000008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-024-00590-y","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:25:31Z","timestamp":1736137531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Boanmycin overcomes bortezomib resistance by inducing DNA damage and endoplasmic reticulum functional impairment in multiple myeloma"],"prefix":"10.1186","volume":"20","author":[{"given":"Jin-Xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo-Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"5","key":"590_CR1","first-page":"497","volume":"327","author":"J Silberstein","year":"2022","unstructured":"Silberstein J, Tuchman S, Grant SJ. What Is Multiple Myeloma? JAMA. 2022;327(5):497.","journal-title":"What Is Multiple Myeloma? JAMA"},{"issue":"10272","key":"590_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"N van de Donk","year":"2021","unstructured":"van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410\u201327.","journal-title":"Lancet"},{"issue":"5","key":"590_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2015.10.014","volume":"28","author":"E Braggio","year":"2015","unstructured":"Braggio E, Kortum KM, Stewart AK. SnapShot: multiple myeloma. Cancer Cell. 2015;28(5):678\u2013e1.","journal-title":"Cancer Cell"},{"issue":"4","key":"590_CR4","first-page":"CD010816","volume":"4","author":"K Scott","year":"2016","unstructured":"Scott K, Hayden PJ, Will A, Wheatley K, Coyne I. Bortezomib for the treatment of multiple myeloma. Cochrane Database Syst Rev. 2016;4(4):CD010816.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"590_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-018-0575-7","volume":"11","author":"Z Zheng","year":"2018","unstructured":"Zheng Z, Fan S, Zheng J, Huang W, Gasparetto C, Chao NJ, et al. Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma. J Hematol Oncol. 2018;11(1):29.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"590_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","volume":"36","author":"S Gandolfi","year":"2017","unstructured":"Gandolfi S, Laubach JP, Hideshima T, Chauhan D, Anderson KC, Richardson PG. The proteasome and proteasome inhibitors in multiple myeloma. Cancer Metastasis Rev. 2017;36(4):561\u201384.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"590_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3748\/wjg.v7.i1.93","volume":"7","author":"YC Deng","year":"2001","unstructured":"Deng YC, Zhen YS, Zheng S, Xue YC. Activity of boanmycin against colorectal cancer. World J Gastroenterol. 2001;7(1):93\u20137.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"590_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/10717544.2014.905651","volume":"23","author":"W Ding","year":"2016","unstructured":"Ding W, Li Y, Hou X, Li G. Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system. Drug Deliv. 2016;23(1):88\u201394.","journal-title":"Drug Deliv"},{"issue":"2","key":"590_CR9","first-page":"143","volume":"18","author":"F Feng","year":"1996","unstructured":"Feng F, Zhou L, Mang Z, Liu H, Sun Y. [Phase I clinical study of a new anticancer drug boanmycin]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1996;18(2):143\u20136.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"4","key":"590_CR10","first-page":"247","volume":"21","author":"F Feng","year":"1999","unstructured":"Feng F, Zhou L. [Phase II clinical study of a new anticancer drug boanmycin]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1999;21(4):247\u201351.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"23","key":"590_CR11","first-page":"4291","volume":"125","author":"ZH Wang","year":"2012","unstructured":"Wang ZH, Ding WM, Hu XD, Li M, Xu HZ, Qian LX. Effect of peritumoral injection of boanmycin hydrochloride within temperature-sensitive in situ gel using Hep-G2 hepatoma nude mice model. Chin Med J (Engl). 2012;125(23):4291\u20135.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"590_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-015-2052-6","volume":"73","author":"DS Schwarz","year":"2016","unstructured":"Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;73(1):79\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1146\/annurev-biochem-072711-163501","volume":"84","author":"LM Westrate","year":"2015","unstructured":"Westrate LM, Lee JE, Prinz WA, Voeltz GK. Form follows function: the importance of endoplasmic reticulum shape. Annu Rev Biochem. 2015;84:791\u2013811.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"590_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","volume":"33","author":"S Zheng","year":"2023","unstructured":"Zheng S, Wang X, Zhao D, Liu H, Hu Y. Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications. Trends Cell Biol. 2023;33(4):312\u201323.","journal-title":"Trends Cell Biol"},{"key":"590_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol. 2015;10:173\u201394.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"590_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"590_CR17","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s00018-021-03756-3","volume":"78","author":"S Xiong","year":"2021","unstructured":"Xiong S, Chng WJ, Zhou J. Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma. Cell Mol Life Sci. 2021;78(8):3883\u2013906.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"590_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10495-015-1119-z","volume":"20","author":"M Yeung","year":"2015","unstructured":"Yeung M, Hurren R, Nemr C, Wang X, Hershenfeld S, Gronda M, et al. Mitochondrial DNA damage by bleomycin induces AML cell death. Apoptosis. 2015;20(6):811\u201320.","journal-title":"Apoptosis"},{"issue":"8","key":"590_CR19","first-page":"855","volume":"21","author":"H Tang","year":"2002","unstructured":"Tang H, Yang XP. [Effect of boanmycin on apoptosis and cell cycle of human esophageal cancer(Eca-109) cells]. Ai Zheng. 2002;21(8):855\u20139.","journal-title":"Ai Zheng"},{"issue":"1","key":"590_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/scdb.2000.0212","volume":"12","author":"MC Ashby","year":"2001","unstructured":"Ashby MC, Tepikin AV. ER calcium and the functions of intracellular organelles. Semin Cell Dev Biol. 2001;12(1):11\u20137.","journal-title":"Semin Cell Dev Biol"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drup.2014.12.001","volume":"18","author":"D Niewerth","year":"2015","unstructured":"Niewerth D, Jansen G, Assaraf YG, Zweegman S, Kaspers GJ, Cloos J. Molecular basis of resistance to proteasome inhibitors in hematological malignancies. Drug Resist Updat. 2015;18:18\u201335.","journal-title":"Drug Resist Updat"},{"issue":"17","key":"590_CR22","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1200\/JCO.19.02515","volume":"38","author":"NS Joseph","year":"2020","unstructured":"Joseph NS, Kaufman JL, Dhodapkar MV, Hofmeister CC, Almaula DK, Heffner LT, et al. Long-term Follow-Up results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in newly diagnosed multiple myeloma. J Clin Oncol. 2020;38(17):1928\u201337.","journal-title":"J Clin Oncol"},{"issue":"3","key":"590_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1378\/chest.103.3.946","volume":"103","author":"MA Mitchell","year":"1993","unstructured":"Mitchell MA, Horneffer MD, Standiford TJ. Multiple myeloma complicated by restrictive cardiomyopathy and cardiac tamponade. Chest. 1993;103(3):946\u20137.","journal-title":"Chest"},{"issue":"11","key":"590_CR24","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3324\/haematol.2020.256388","volume":"106","author":"DM Stephens","year":"2021","unstructured":"Stephens DM, Boucher K, Kander E, Parikh SA, Parry EM, Shadman M, et al. Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration. Haematologica. 2021;106(11):2845\u201352.","journal-title":"Haematologica"},{"issue":"1","key":"590_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s10020-024-00821-y","volume":"30","author":"F Chen","year":"2024","unstructured":"Chen F, Zhao W, Du C, Chen Z, Du J, Zhou M. Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51. Mol Med. 2024;30(1):54.","journal-title":"Mol Med"},{"issue":"2","key":"590_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/CAD.0000000000000304","volume":"27","author":"P Chen","year":"2016","unstructured":"Chen P, Guo H, Chen J, Fu Y. The chemotherapeutic drug boanmycin induces cell senescence and senescence-associated secretory phenotype factors, thus acquiring the potential to remodel the tumor microenvironment. Anticancer Drugs. 2016;27(2):84\u20138.","journal-title":"Anticancer Drugs"},{"issue":"16","key":"590_CR27","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1007\/s00253-018-9129-8","volume":"102","author":"J Kong","year":"2018","unstructured":"Kong J, Yi L, Xiong Y, Huang Y, Yang D, Yan X, et al. The discovery and development of microbial bleomycin analogues. Appl Microbiol Biotechnol. 2018;102(16):6791\u20138.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"41","key":"590_CR28","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.1021\/ja0722729","volume":"129","author":"Q Ma","year":"2007","unstructured":"Ma Q, Xu Z, Schroeder BR, Sun W, Wei F, Hashimoto S, et al. Biochemical evaluation of a 108-member deglycobleomycin library: viability of a selection strategy for identifying bleomycin analogues with altered properties. J Am Chem Soc. 2007;129(41):12439\u201352.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"590_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrc1547","volume":"5","author":"J Chen","year":"2005","unstructured":"Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat Rev Cancer. 2005;5(2):102\u201312.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"590_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/15548627.2017.1409405","volume":"14","author":"K Wang","year":"2018","unstructured":"Wang K, Zhang T, Lei Y, Li X, Jiang J, Lan J, et al. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux. Autophagy. 2018;14(2):269\u201382.","journal-title":"Autophagy"},{"issue":"4","key":"590_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ajh.26083","volume":"96","author":"JL Kaufman","year":"2021","unstructured":"Kaufman JL, Gasparetto C, Schjesvold FH, Moreau P, Touzeau C, Facon T, et al. Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed\/refractory t(11;14) multiple myeloma. Am J Hematol. 2021;96(4):418\u201327.","journal-title":"Am J Hematol"},{"issue":"8","key":"590_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.bcp.2009.12.008","volume":"79","author":"D Brunelli","year":"2010","unstructured":"Brunelli D, Tavecchio M, Falcioni C, Frapolli R, Erba E, Iori R, et al. The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. Biochem Pharmacol. 2010;79(8):1141\u20138.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"590_CR33","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1002\/cti2.1007","volume":"7","author":"N Nikesitch","year":"2018","unstructured":"Nikesitch N, Lee JM, Ling S, Roberts TL. Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance. Clin Transl Immunol. 2018;7(1):e1007.","journal-title":"Clin Transl Immunol"},{"issue":"3","key":"590_CR34","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3892\/mmr.2016.5533","volume":"14","author":"X Dong","year":"2016","unstructured":"Dong X, Liao Y, Liu N, Hua X, Cai J, Liu J, et al. Combined therapeutic effects of bortezomib and anacardic acid on multiple myeloma cells via activation of the endoplasmic reticulum stress response. Mol Med Rep. 2016;14(3):2679\u201384.","journal-title":"Mol Med Rep"},{"key":"590_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcvm.2019.00010","volume":"6","author":"Q Chen","year":"2019","unstructured":"Chen Q, Thompson J, Hu Y, Das A, Lesnefsky EJ. Cardiac specific knockout of p53 decreases ER stress-Induced mitochondrial damage. Front Cardiovasc Med. 2019;6:10.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"590_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/cdd.2017.96","volume":"24","author":"I Lopez","year":"2017","unstructured":"Lopez I, Tournillon AS, Prado Martins R, Karakostis K, Malbert-Colas L, Nylander K, et al. p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress. Cell Death Differ. 2017;24(10):1717\u201329.","journal-title":"Cell Death Differ"},{"issue":"6","key":"590_CR37","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3892\/ijmm.2013.1530","volume":"32","author":"YY Chen","year":"2013","unstructured":"Chen YY, Sun LQ, Wang BA, Zou XM, Mu YM, Lu JM. Palmitate induces autophagy in pancreatic beta-cells via endoplasmic reticulum stress and its downstream JNK pathway. Int J Mol Med. 2013;32(6):1401\u20136.","journal-title":"Int J Mol Med"},{"issue":"6","key":"590_CR38","doi-asserted-by":"publisher","first-page":"e21533","DOI":"10.1371\/journal.pone.0021533","volume":"6","author":"H Lee","year":"2011","unstructured":"Lee H, Park MT, Choi BH, Oh ET, Song MJ, Lee J, et al. Endoplasmic reticulum stress-induced JNK activation is a critical event leading to mitochondria-mediated cell death caused by beta-lapachone treatment. PLoS ONE. 2011;6(6):e21533.","journal-title":"PLoS ONE"},{"key":"590_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","volume":"97","author":"V Della Latta","year":"2015","unstructured":"Della Latta V, Cecchettini A, Del Ry S, Morales MA. Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res. 2015;97:122\u201330.","journal-title":"Pharmacol Res"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-024-00590-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T13:07:02Z","timestamp":1736168822000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-024-00590-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1186\/s13062-024-00590-y","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bone marrow mononuclear cells (BMMCs) were collected from MM patients with approval from the Institute Research Ethics Committee (No. 2024014) of The Second Affiliated Hospital of the Chinese University of Hong Kong (Shenzhen), following the Helsinki Declaration. The animal experiments were approved by the Institutional Animal Care and Use Committee of The Chinese University of Hong Kong (Shenzhen) (No. CUHKSZ-AE2021011), following the WMA statement on animal use in biomedical research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}